ArticleThe Lancet regional health. Southeast Asia2026

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial.

Praveen Kumar Marimuthu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.